A strong connection with Iran appears to have killed attempts by listed biopharmaceutical company Immuron to take over the maker of Australia’s best and only COVID-19 vaccine.
Under a deal negotiated in May, Immuron agreed to pay about $100 million in cash and scrip for privately owned biotechnology company Vaxine, which was founded by Nikolai Petrovsky.
Loading...
Tony Boyd is the former Chanticleer columnist. He has more than 35 years' experience as a finance journalist. Connect with Tony on Twitter. Email Tony at tony.boyd@afr.com
